VolitionRx enters CEO employment agreement with Dr. Michel for Belgian subsidiary; consulting fee amended

VOLITIONRX LTD

Employment agreement with Dr. Gaetan Michel as CEO of Belgian Volition, effective Sept 1, 2024, with €12,000/month salary plus 13th month bonus.
Consulting agreement amendment with 3F Management SRL increases monthly fee to €15,598 from Nov 1, 2024; variable bonus up to €26,390.
Dr. Michel also serves as COO of parent, CEO of Volition America, and Manager of Volition Veterinary Diagnostics.
Combined aggregate annual compensation is materially consistent with prior arrangements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.